This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While breast cancer is often thought of as a singular diagnosis, it is actually an umbrella term that encompasses several subtypes of the disease — many of which have been discovered in recent years due to continual advancement in the oncology research space. Traditionally, breast cancers are grouped into subtypes according to the Tumor, Nodes, and Metastasis system of staging breast cancer, the reproductive status of the patient, and the types of biological markers that are found in the cancer
This chart shows the pharmaceutical companies with the most patents in Mexico. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Mexico? appeared first on DrugPatentWatch - Make Better Decisions.
Last week, Cytel Director & Research Principal Louis Dron discussed new FDA guidance on the design and conduct of trials incorporating an external control group, sometimes known as a synthetic control arm. But what are synthetic control arms and what are the potential benefits to this clinical trial design?
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Did you know that February is American Heart Month ? This month is dedicated to raising awareness for and providing education on heart health, high blood pressure, and cardiovascular disease.
Is the gold rush in copay accumulators and maximizers slowing down? Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs. Accumulator adoption has plateaued, while maximizer use has overtaken accumulators. Patients who take a single-source, brand-name specialty drug for autoimmune conditions, multiple sclerosis, and oncology increasingly face these benefit designs.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Is the gold rush in copay accumulators and maximizers slowing down? Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs. Accumulator adoption has plateaued, while maximizer use has overtaken accumulators. Patients who take a single-source, brand-name specialty drug for autoimmune conditions, multiple sclerosis, and oncology increasingly face these benefit designs.
This chart shows the pharmaceutical companies with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Cyprus? appeared first on DrugPatentWatch - Make Better Decisions.
Drug development is an immensely complex undertaking consisting of many different, interconnected processes. Specialist regulatory affairs consultants offer services to companies operating across this challenging industry. Pharmaceutical companies and the drugs they develop must meet stringent regulations before products are approved for the market.
When sponsors advertise a clinical trial online, they will typically either provide sites with individual advertising budgets or work with a clinical trial recruitment company to create outreach materials. Once created, these materials will undergo the IRB approval process and then be distributed across online channels such as Facebook and Google Ads.
On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. This report—our fourteenth edition—remains the most comprehensive, fact-based tool for understanding the entire U.S. drug pricing, reimbursement, and dispensing system. 12 chapters, 480+ pages, 241 exhibits, 900+ endnotes: There is nothing else available that comes close to this valuable resource.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations are one of the categories for which the FDA grants… The post Pharmaceutical companies with the most ‘New Combination’ drugs appeared first on DrugPatentWatch - Make Better Decisions.
Global healthcare systems require medical devices that are safe and effective in the diagnosis, treatment and prevention of diseases, and physicians rely on a wide range of medical devices to help identify and treat said ailments.
As the snow was falling on us at the end of January a handful of our team packed their bags and flew down to the sun in Silicon Valley for the 2023 Precision Medicine World Conference. In addition to extra sunscreen, we brought down our bright pink booth to show off everything we love about DrugBank. As a distributed team these in-person conferences are highly cherished opportunities for us to engage with our customers and industry leaders, and soak up valuable insights.
By Adrian Cortes Sanchon Collaboration is the cornerstone of innovation. An ongoing collaboration between Tecan, manufacturer of robust, high-quality liquid handling automation systems, its partner, Macherey-Nagel, developer of nucleic acid extraction kits, and their customer, a research group from Jülich Research Center, in Germany, is proving to create fertile ground for innovation and sustainable solutions.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
How do you know your experimental therapy is working? Sometimes, it can be as simple to determine as comparing drug A to placebo and measuring the physiological result with an approved assay. But what does “working” really mean when efficacy means something subjective, like quality of life, reduced psychiatric events, or less symptoms? In most cases, the results you are really looking for and trying to prove in a trial can be complex.
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are three patents… The post New patent for Aveo Pharms drug FOTIVDA appeared first on DrugPatentWatch - Make Better Decisions.
Simulation-guided design is quickly becoming a novel feature of modern drug development. Its foundational promise is to harness the power of data to create robust trial strategy. With high-compute power and incredible speed, decision-makers can now create strategy that de-risks clinical trials while offering necessary flexibility when challenges arise, and clarity to align on goals.
Surveillance is the cornerstone of public health practice, including in occupational safety and health (OSH). OSH surveillance systems have the ability to generate data that drives decision making and action.1, 2 There are multiple steps in a surveillance system including timely and accurate data collection; data quality monitoring; data management; data analysis; interpretation of results; and dissemination and application of information.1 OSH researchers have used surveillance systems to impro
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
The past year was difficult financially, particularly in the biotech industry. Funding dried up after a period of rapid investing that pushed capital allocators further up the risk curve. A number of investments during this time may also have been motivated by the fear of missing out. These anecdotal struggles were highlighted in industry research conducted by PPD, the clinical research business of Thermo Fisher Scientific.
This week we’re spotlighting Omotola Komaiya , a Product Analyst on our Analytics team. Omotola shares below more about her career journey in science and then tech, how our Analytics team plays an important role in building products for our customers, and the best party she has ever thrown! Read on to learn more.
The latest release of the Platform — 23.02 — is now available at platform.opentargets.org. Key points In addition to regular updates from our data providers, we have a number of new features in this release. New evidence for target-disease associations Additional data for metabolic biomarkers added to our Gene Burden widget QTL-based direction of effect included in evidence from Open Targets Genetics Improved target annotation data Integration of Target safety evidence from AOPWiki
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Australia? appeared first on DrugPatentWatch - Make Better Decisions.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Rare Disease Day on February 28th is a chance for rare disease communities to come together as one and join in conversation with stakeholders searching for treatments, raising money to support research, and changing the way healthcare and governments interact with patients. With so many important discussions happening this year between stakeholders, it is impossible to be a part of them all.
Working with universities can bring tremendous benefits to a company. Access to cutting-edge research drives innovation and accelerates the development of new products and technologies. Navigating the often-complex world of academic partnerships can be challenging, however, and a crucial aspect of funded research is often overlooked – indirect costs.
The motilin receptor is a heterotrimeric G-protein-coupled receptor (GPCR38) involved with regulating stomach motility. 1,2 Since its discovery in 1999 researchers have been keen to develop compounds that can modify this receptor. 3 In this article, we will explore everything that is known about its function, physiology, and pharmacology.
Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are nineteen patents… The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on DrugPatentWatch - Make Better Decisions.
Synthetic biology, the answer to ageing, and more at Research & Innovation 2023 Synthetic biology, the answer to ageing, and more at Research & Innovation 2023 The life sciences and drug discovery landscape continues to advance at pace, delivering innovations with the potential to transform patients’ lives across the world. But keeping up with these advancements is no easy feat.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
98 
Let's personalize your content